Is MetLife (MET) overvalued or fairly valued?

MarketChacha shows MetLife's valuation in context — a trailing P/E of about 19.9, a forward P/E of about 9.1, a price-to-book of about 2.3 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does MetLife's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (4.84×) from reported figures — education, not a rating.

What is MetLife's revenue?

MetLife reported revenue of $2.4B for FY2025, with net profit of $3.4B, per official filings.

What is the share price of MetLife (MET)?

MetLife last traded at $100.98 (+1.4% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

MetLife

MET · NYSE · Financials · United States

Snapshot

TickerMET

ExchangeNYSE

SectorFinancials

IndustryInsurance - Life

CountryUnited States

Employees46,000

HeadquartersNew York, United States

Websitewww.metlife.com

Filings tracked25

About MetLife

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Who owns it

Insiders16.4%
Institutions78.3%
Public & other5.3%

1,934 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.8.05%
Dodge & Cox Inc.7.53%
Vanguard Capital Management LLC5.51%
Vanguard Portfolio Management LLC4.67%
State Street Corporation3.94%
Price (T.Rowe) Associates Inc3.31%
Geode Capital Management, LLC2.07%
Morgan Stanley1.95%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion4.84×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend70.8% → 138.7%

Margin has expanded by about 67.9 points — the business is getting more profitable.

Growth qualityrev 5% · PAT 46%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $20.5B · EPS 2.62

Est. earnings growth +5.2%

Next fiscal year

Rev $83.2B · EPS 11.16

Est. earnings growth +9.3%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$2.4B

Net margin

138.7%

ROE

11.9%

Revenue CAGR (2y)

+4.5%

Profit CAGR (2y)

+46.3%

EPS (FY2025)

4.71

Net profit (FY2025)

$3.4B

Ask MarketChacha about MET

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$2.4B	$3.4B	4.71	138.7%	11.9%
FY2024	$2.2B	$4.4B	5.94	197.1%	16.1%
FY2023	$2.2B	$1.6B	1.81	70.8%	5.3%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$724.0M	$736.0M	1.09	101.7%
2026Q1	$734.0M	$1.2B	1.74	161.4%
2025Q3	$621.0M	$896.0M	1.22	144.3%
2025Q2	$604.0M	$729.0M	1.03	120.7%
2025Q1	$611.0M	$945.0M	1.28	154.7%
2024Q3	$554.0M	$1.3B	1.81	242.2%
2024Q2	$558.0M	$946.0M	1.28	169.5%
2024Q1	$577.0M	$867.0M	1.10	150.3%
2023Q4	$19.0B	$607.0M	0.77	3.2%
2023Q3	$554.0M	$489.0M	0.56	88.3%
2023Q2	$546.0M	$402.0M	0.48	73.6%
2023Q1	$562.0M	$80.0M	0.02	14.2%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Other events, Exhibits
SEC8/17/2026material
10-Q filing
SEC8/6/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC8/5/2026material
8-K — Reg FD disclosure
SEC6/29/2026material
8-K — Shareholder vote results
SEC6/22/2026material
8-K — Other events, Exhibits
SEC5/15/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC5/6/2026material
8-K — Reg FD disclosure
SEC4/7/2026material
8-K — Other events, Exhibits
SEC3/5/2026material
8-K — Material financial obligation, Other events, Exhibits
SEC2/26/2026material
8-K — Executive/director change
SEC2/24/2026material
10-K filing
SEC2/19/2026
8-K — Other events, Exhibits
SEC2/17/2026material
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC2/4/2026material
8-K — Reg FD disclosure, Exhibits
SEC1/9/2026material

2025

8-K — Reg FD disclosure, Other events, Exhibits
SEC12/30/2025material
8-K — Reg FD disclosure
SEC12/22/2025material
8-K — Reg FD disclosure, Exhibits
SEC12/1/2025material
8-K — Other events, Exhibits
SEC11/17/2025material
10-Q filing
SEC11/7/2025
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC11/5/2025material
8-K — Bylaw/charter change, Exhibits
SEC10/14/2025material
8-K — Reg FD disclosure
SEC9/22/2025material
8-K — Other events, Exhibits
SEC9/15/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.